Bayer Schering Pharma Financial Statements
Bayer Schering Pharma Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
This data is provided as per license from EDGAR Online
Bayer Schering Pharma Income Statement
| 2005 | 2004 | 2003 | |
|---|---|---|---|
| Revenue ($ mil.) | 6,286.8 | 6,695.1 | 6,309.0 |
| Gross Profit ($ mil.) | 4,799.2 | 5,049.6 | 4,591.0 |
| Operating Income ($ mil.) | 1,099.1 | 1,026.0 | 791.0 |
| Total Net Income ($ mil.) | 696.4 | 642.6 | 616.0 |
| Diluted EPS (Net Income) | -- | -- | -- |
Bayer Schering Pharma Stock Quote & Chart
07/15/08 16:21:05 EST •
Nasdaq Other OTC •
163.00
•
 0.0000
•
0.0000 %
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Bayer Schering Pharma Competitive Intelligence
| Barr Pharmaceuticals | Ortho-McNeil Pharmaceutical | Wyeth | |
|---|---|---|---|
| Annual Sales ($ mil.) | 2,500.6 | 15.8 | 22,399.8 |
| Employees | 8,900 | 121 | 50,527 |
| Market Cap ($ mil.) | 6,172.7 | -- | 64,400.2 |
